BioCentury
ARTICLE | Company News

Intercept Pharmaceuticals management update

March 11, 2013 7:00 AM UTC

Intercept Pharmaceuticals Inc. (NASDAQ:ICPT), New York, N.Y. Business: Hepatic, Endocrine/Metabolic Hired: Daniel Regan as chief commercial officer, a newly created position, formerly chief commercial...